An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy

dc.contributor.authorSevindik, Omur Gokmen
dc.contributor.authorOzkurt, Zubeyde Nur
dc.contributor.authorBoga, Can
dc.contributor.authorBesisik, Sevgi Kalayoglu
dc.contributor.authorIpek, Yildiz
dc.contributor.authorGeduk, Ayfer
dc.contributor.authorHarmandali, Aybuke
dc.date.accessioned2024-02-23T14:49:27Z
dc.date.available2024-02-23T14:49:27Z
dc.date.issued2021
dc.departmentNEÜen_US
dc.description.abstract[Abstract Not Availabe]en_US
dc.identifier.endpageS103en_US
dc.identifier.issn2152-2650
dc.identifier.issn2152-2669
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpageS102en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12452/18197
dc.identifier.volume21en_US
dc.identifier.wosWOS:000717640800179en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherCig Media Group, Lpen_US
dc.relation.ispartofClinical Lymphoma Myeloma & Leukemiaen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleAn interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapyen_US
dc.typeConference Objecten_US

Dosyalar